EHD2, a novel HIF target gene, is a promising biomarker in clear cell renal cell carcinoma.
Yufeng Chen(Shanghai University of Traditional Chinese Medicine), Qingchuan Zhang(Shanghai University of Traditional Chinese Medicine), Song Xue(Shanxi Medical University), Jian Shi(Shandong Institute of Automation), Chunfeng He(Chinese Academy of Agricultural Sciences)
PubMed
January 1, 2023
Cited by 0
Related Papers
Biochar supported nanoscale zerovalent iron composite used as persulfate activator for removing trichloroethylene
|Bioresource Technology|2014|600
Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy
|Bioactive Materials|2021|203
Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma
|Oncotarget|2017|99
CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
|Journal of Translational Medicine|2021|93
The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis
|Scientific Reports|2017|82